By apyxmedical In 2020 Shareholder News, Case Study, J-Plasma, RenuvionPosted November 23, 2020APYX MEDICAL CORPORATION ANNOUNCES APPROVAL FROM FDA TO BEGIN PHASE II OF U.S. IDE STUDY READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted November 9, 2020APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS READ MORE
By apyxmedical In 2020 Shareholder News, Case Study, J-Plasma, RenuvionPosted November 9, 2020APYX MEDICAL CORPORATION ANNOUNCES UPDATES ON U.S. IDE CLINICAL STUDIES READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted October 20, 2020APYX MEDICAL CORPORATION ANNOUNCES TWO PEER-REVIEWED CLINICAL PUBLICATIONS EVALUATING RENUVION’S HELIUM PLASMA TECHNOLOGY READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted October 1, 2020APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2020 FINANCIAL RESULTS ON NOVEMBER 9, 2020 READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted August 31, 2020APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN SEPTEMBER READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted August 7, 2020APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted June 25, 2020APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2020 FINANCIAL RESULTS ON AUGUST 10, 2020 READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted June 22, 2020APYX MEDICAL CORPORATION ANNOUNCES REGULATORY CLEARANCE TO MARKET AND SELL ITS HELIUM PLASMA TECHNOLOGY PRODUCTS IN FIVE NEW COUNTRIES READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted May 11, 2020APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS READ MORE
